» Articles » PMID: 30081879

Recommendations for the Screening of Paediatric Latent Tuberculosis Infection in Indigenous Communities: a Systematic Review of Screening Strategies Among High-risk Groups in Low-incidence Countries

Overview
Publisher Biomed Central
Specialty Public Health
Date 2018 Aug 8
PMID 30081879
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Tuberculosis (TB) continues to be a global public health concern. Due to the presence of multiple risk factors such as poor housing conditions and food insecurity in Canadian Indigenous communities, this population is at particularly high risk of TB infection. Given the challenges of screening for latent TB infection (LTBI) in remote communities, a synthesis of the existing literature regarding current screening strategies among high-risk groups in low-incidence countries is warranted, in order to provide an evidence base for the optimization of paediatric LTBI screening practices in the Canadian Indigenous context.

Methods: A literature search of the Embase and Medline databases was conducted, and studies pertaining the evaluation of screening strategies or screening tools for LTBI in paediatric high-risk groups in low-incidence countries were included. Studies focusing on LTBI screening in Indigenous communities were also included, regardless of whether they focused on a paediatric population. Their results were summarized and discussed in the context of their relevance to screening strategies suitable to the Canadian Indigenous setting. Grey literature sources such as government reports or policy briefs were also consulted.

Results: The initial literature search returned 327 studies, with 266 being excluded after abstract screening, and 36 studies being included in the final review (original research studies: n = 25, review papers or policy recommendations: n = 11). In the examined studies, case identification and cost-effectiveness of universal screening were low in low-incidence countries. Therefore, studies generally recommended targeted screening of high-risk groups in low-incidence countries, however, there remains a lack of consensus regarding cut-offs for the incidence-based screening of high-risk communities, as well as regarding the utility and prioritization of individual risk-factor-based screening of high-risk groups. The utility of the TST compared to IGRAs for LTBI detection in the pediatric population also remains contested.

Conclusions: Relevant strategies for targeted screening in the Canadian Indigenous context include community-level incidence-based screening (screening based on geographic location within high-incidence communities), as well as individual risk-factor-based screening, taking into account pertinent risk factors in Indigenous settings, such as poor housing conditions, malnutrition, contact with an active case, or the presence of relevant co-morbidities, such as renal disease.

Citing Articles

Popularity of HIV self-tests may say more about the state of our primary care system than about the device itself.

Musten A, OByrne P Can Commun Dis Rep. 2024; 50(12):436-446.

PMID: 39664234 PMC: 11629877. DOI: 10.14745/ccdr.v50i12da04.


Diagnosis of tuberculosis infection in children with a novel skin test and the traditional tuberculin skin test: An observational study.

Fritschi N, Gureva T, Eliseev P, Jackson C, Milanzi E, Crichton S PLoS One. 2024; 19(8):e0293272.

PMID: 39190640 PMC: 11349085. DOI: 10.1371/journal.pone.0293272.


Research Questions and Priorities for Pediatric Tuberculosis: A Survey of Published Systematic Reviews and Meta-Analyses.

Vukugah T, Ntoh V, Akoku D, Leonie S, Jacob A Tuberc Res Treat. 2022; 2022:1686047.

PMID: 35178252 PMC: 8844079. DOI: 10.1155/2022/1686047.


Tuberculosis in Adolescents and Young Adults: Emerging Data on TB Transmission and Prevention among Vulnerable Young People.

Laycock K, Enane L, Steenhoff A Trop Med Infect Dis. 2021; 6(3).

PMID: 34449722 PMC: 8396328. DOI: 10.3390/tropicalmed6030148.


High food insecurity in Latinx families and associated COVID-19 infection in the Greater Bay Area, California.

Escobar M, Mendez A, Encinas M, Villagomez S, Wojcicki J BMC Nutr. 2021; 7(1):23.

PMID: 34112257 PMC: 8192129. DOI: 10.1186/s40795-021-00419-1.


References
1.
Rose W, Kitai I, Kakkar F, Read S, Behr M, Bitnun A . Quantiferon Gold-in-tube assay for TB screening in HIV infected children: influence of quantitative values. BMC Infect Dis. 2014; 14:516. PMC: 4181619. DOI: 10.1186/1471-2334-14-516. View

2.
Alvarez G, Van Dyk D, Davies N, Aaron S, Cameron D, Desjardins M . The feasibility of the interferon gamma release assay and predictors of discordance with the tuberculin skin test for the diagnosis of latent tuberculosis infection in a remote Aboriginal community. PLoS One. 2014; 9(11):e111986. PMC: 4227715. DOI: 10.1371/journal.pone.0111986. View

3.
Kitai I, Morris S, Kordy F, Lam R . Diagnosis and management of pediatric tuberculosis in Canada. CMAJ. 2017; 189(1):E11-E16. PMC: 5224946. DOI: 10.1503/cmaj.151212. View

4.
Grare M, Derelle J, Dailloux M, Laurain C . [Difficulties of TB diagnosis in children: QuantiFERON TB Gold In-Tube as useful tool]. Arch Pediatr. 2009; 17(1):77-85. DOI: 10.1016/j.arcped.2009.07.021. View

5.
Sali M, Buonsenso D, Goletti D, DAlfonso P, Zumbo A, Fadda G . Accuracy of QuantiFERON-TB Gold Test for Tuberculosis Diagnosis in Children. PLoS One. 2015; 10(10):e0138952. PMC: 4595419. DOI: 10.1371/journal.pone.0138952. View